ARTICLE | Clinical News
Demegen preclinical data
March 27, 2000 8:00 AM UTC
DBOT collaborators presented data showing that topical D2A21 administration prevented growth of Pseudomonas aeruginosa bacteria in burn wounds in an animal model, and significantly reduced bacterial g...